Byline: MARLENE CIMONS - Los Angeles Times
The U.S. Food and Drug Administration Thursday approved the first drug for the treatment of Alzheimer's disease, a debilitating brain ailment that robs millions of elderly Americans of their memory, independence and dignity.
Tacrine hydrochloride, or THA, which will be marketed under the brand name Cognex, has been shown in two trials to provide small but meaningful benefit for some patients suffering from mild to moderate Alzheimer's.
"Tacrine is the first drug shown to have some effect on the disease's devastating symptoms," FDA Commissioner David A. Kessler said in a statement. "It is not a cure for Alzheimer's disease, but it provides some …
No comments:
Post a Comment